Recently, Johns Hopkins University (USA) has identified three new unusual mutations in two types of proteins found in brain cells that lead to brain cancer.
Researchers at Johns Hopkins University (USA) have identified three new unusual mutations in two types of proteins that disrupt the normal functioning of cells, leading to brain cancer.
This research team emphasizes that these findings are significant as they pave the way for the application of effective cancer treatment therapies, since the two types of unusually mutated proteins are located on the cell surface and anti-cancer drugs can directly target them.
Recent advancements in technology and genetic information have facilitated the identification of molecular-level mutations that cause cancer.
The next phase in the quest for cancer treatment therapies involves finding agents that inhibit these genetic mutations and developing strategies to reverse the disease-causing effects of these mutations.
